Provided herein are compounds of the formula (I):
as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, COPD.
[EN] LEUKOTRIENE B4 INHIBITORS<br/>[FR] INHIBITEURS DE LEUCOTRIÈNE B4
申请人:HOFFMANN LA ROCHE
公开号:WO2009109483A1
公开(公告)日:2009-09-11
Provided herein are compounds of the formula (I), as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, COPD.
LEUKOTRIENE B4 INHIBITORS
申请人:Dominique Romyr
公开号:US20090227603A1
公开(公告)日:2009-09-10
Provided herein are compounds of the formula (I):
as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, COPD
Efficient Synthesis of Aryl Methyl Sulfide Derivatives Using (Methylthio)trimethylsilane as Methylthiolation Reagent
作者:Qi Qiao、Romyr Dominique、Achyutharao Sidduri、Jianping Lou、Robert A. Goodnow
DOI:10.1080/00397910903531664
日期:2010.11.16
The synthesis of various aryl methyl sulfides has been achieved by treatment of nitroarenes with a combination of (methylthio)trimethylsilane and cesium carbonate in dimethylsulfoxide. This reaction gives access to aryl methyl sulfide derivatives in high yields.